Alternatives to Coefficient Bio

OpenAI is an AI research and deployment company dedicated to ensuring that artificial general intelligence benefits all of humanity.

Pioneering AI research and development to solve intelligence and advance science for humanity.

Mistral AI provides frontier AI models, assistants, and agents with compute infrastructure and services.

Zyvorx is a biotechnology company using AI and computational biology to accelerate drug discovery and development.

Anthropic is an AI safety and research company building reliable, interpretable, and steerable AI systems, best known for the Claude family of models.

Anthropic is an AI safety and research company that develops reliable, interpretable, and steerable AI systems, including the Claude family of large language models.

Artificial intelligence research and deployment company focused on developing advanced AI models like GPT-5.6 and GPT-Live, offering products such as ChatGPT and an API platform.

An AI research and deployment company focused on ensuring artificial general intelligence benefits all of humanity.

AI research and deployment company building advanced language models like ChatGPT, DALL-E, and Whisper.

SpaceXAI is an artificial intelligence and social media company, a subsidiary of SpaceX, developing the generative AI chatbot Grok and the social network X.

Meta's division dedicated to advancing AI research and developing AI models and tools.

Building a fault-tolerant quantum computer using photonics and silicon manufacturing.

Ilya Sutskever's AI safety-focused research lab with the singular goal of building safe superintelligent AI.

AI research and deployment company building safe and beneficial AGI.

AI startup led by Jeff Bezos.

AI company developing advanced AI models for complex reasoning and problem-solving in high-stakes environments.

Quantum computer hardware and software developer for various industries.

Develops AI that surpasses expert capabilities in science and technology, scaling expert intelligence.

Developing advanced physical AI and humanoid robots for industrial and domestic environments, focusing on real-world performance and learning through demonstration.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

YzI Labs is a startup focused on developing advanced AI models and infrastructure.

Chinese AI company developing advanced models for Artificial General Intelligence (AGI).

Astra Nova is a startup focused on developing advanced AI models for complex problem-solving.

AI research lab focused on developing advanced AI systems and foundational models.

AI model development and infrastructure strategy, focusing on securing significant computing power through innovative procurement.

Building General Biological Intelligence

A research lab building advanced AI agents for complex, real-world tasks.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Elorian AI builds native multimodal AI for visual reasoning with a purpose-built architecture, aiming to advance AI systems closer to human-like understanding of the physical world.

Frontier AI lab building a unified reading platform for radiologists.

Developing advanced AI models for complex problem-solving and scientific discovery.

AI research lab focused on developing advanced AI models and systems.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Early-stage venture capital firm focused on deep technology and frontier AI.

Developing advanced AI models for complex problem-solving and scientific discovery.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Frontier AI is building advanced AI models and infrastructure for complex reasoning and problem-solving.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Developing advanced AI models and specialized hardware for artificial general intelligence.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A vertically-integrated procurement platform for the life sciences industry.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Profluent is developing advanced AI models for scientific discovery and complex problem-solving.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Neptune provides a data platform for businesses to manage and analyze their data.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.